CPIG
BIVV

Chicago Partners Investment Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Chicago Partners Investment Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-270
Closed -$15K – 961
2017
Q4 		$15K Hold
270
– – ﹤0.01% 686
2017
Q3 		$15K Hold
270
– – ﹤0.01% 708
2017
Q2 		$16K Buy
270
+218
+419% +$12.4K ﹤0.01% 537
2017
Q1 		$3K Buy
+52
New +$2.56K ﹤0.01% 519

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Chicago Partners Investment Group's BIVV Position: Q1 2018 in Review

Chicago Partners Investment Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 270 shares — an estimated $15K sold.

Chicago Partners Investment Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $16K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Chicago Partners Investment Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 270 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $15K.
  • Chicago Partners Investment Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Chicago Partners Investment Group's Bioverativ Inc. Common Stock position peaked at $16K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Chicago Partners Investment Group's 13F filing for Q1 2018, filed 27 Apr 2018.